Documents
Application Sponsors
ANDA 079003 | WATSON LABS TEVA | |
Marketing Status
Application Products
001 | TABLET;ORAL | EQ 150MG BASE | 0 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
FDA Submissions
| ORIG | 1 | AP | 2012-03-20 | |
LABELING; Labeling | SUPPL | 2 | AP | 2017-01-24 | STANDARD |
LABELING; Labeling | SUPPL | 7 | AP | 2017-01-24 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 15 |
SUPPL | 2 | Null | 15 |
SUPPL | 7 | Null | 7 |
TE Codes
CDER Filings
WATSON LABS TEVA
cder:Array
(
[0] => Array
(
[ApplNo] => 79003
[companyName] => WATSON LABS TEVA
[docInserts] => ["",""]
[products] => [{"drugName":"IBANDRONATE SODIUM","activeIngredients":"IBANDRONATE SODIUM","strength":"EQ 150MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"IBANDRONATE SODIUM","submission":"IBANDRONATE SODIUM","actionType":"EQ 150MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)